Cargando…
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6...
Autores principales: | Scotto, Riccardo, Pinchera, Biagio, Perna, Francesco, Atripaldi, Lidia, Giaccone, Agnese, Sequino, Davide, Zappulo, Emanuela, Sardanelli, Alessia, Schiano Moriello, Nicola, Stanziola, Anna, Bocchino, Marialuisa, Gentile, Ivan, Sanduzzi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924557/ https://www.ncbi.nlm.nih.gov/pubmed/33672761 http://dx.doi.org/10.3390/ijerph18042078 |
Ejemplares similares
-
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience
por: Gentile, Ivan, et al.
Publicado: (2021) -
Update on the Management of Surgical Site Infections
por: Pinchera, Biagio, et al.
Publicado: (2022) -
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience
por: Moriello, Nicola Schiano, et al.
Publicado: (2023) -
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study
por: Gentile, Ivan, et al.
Publicado: (2022) -
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients
por: Biagio, Pinchera, et al.
Publicado: (2022)